Kayyem Jon Faiz → Inhibrx Biosciences, Inc. INBX

Stake: 7.90% Shares: 1,149,046 CUSIP: 45720N103 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 9.04

3,433,872 shares short · -0.4% vs prior

Institutional Consensus · 2026-03-31

Held by elite portfolio managers

1 holder · $96.66M

Viking Global

Post-Filing Returns · since 2024-06-03 on INBX

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 100.75 on closest trading day on/after 2024-06-03. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Inhibrx Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-26	SCHEDULE	Lappe Mark	6.40%	925,413	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →